Maria Gisella Cavallo

Pubblicazioni

Titolo Pubblicato in Anno
Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study DIABETES, OBESITY AND METABOLISM 2024
Neurotensin: Linking metabolism and cardiovascular disease ATHEROSCLEROSIS 2024
Biliverdin reductase-A integrates insulin signaling with mitochondrial metabolism through phosphorylation of GSK3β REDOX BIOLOGY 2024
PAR level mediates the link between ROS and inflammatory response in patients with type 2 diabetes mellitus REDOX BIOLOGY 2024
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk THE LANCET REGIONAL HEALTH. EUROPE 2024
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes DIABETES/METABOLISM RESEARCH AND REVIEWS 2023
A sub-analysis of the SAGE study in Italy indicates good glycemic control in type 1 diabetes NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2023
Dynamic Changes of BVRA Protein Levels Occur in Response to Insulin: A Pilot Study in Humans INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Liver fibrosis is associated with impaired bone mineralization and microstructure in obese individuals with non-alcoholic fatty liver disease HEPATOLOGY INTERNATIONAL 2023
Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 Diabetes THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2023
Neurotensin Gene rs2234762 C>G Variant Associates with Reduced Circulating Pro-NT Levels and Predicts Lower Insulin Resistance in Overweight/Obese Children INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Reduced High-Density Lipoprotein Cholesterol Is an Independent Determinant of Altered Bone Quality in Women with Type 2 Diabetes INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Short-term effectiveness of dapagliflozin versus {DPP}-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2023
Glycated haemoglobin in the first year after diagnosis of type 1 diabetes is an independent risk factor for diabetic retinopathy: The IMDIAB 25 years follow-up study DIABETES, OBESITY AND METABOLISM 2023
Reduced Lipopolysaccharide-Binding Protein (LBP) Levels Are Associated with Non-Alcoholic Fatty Liver Disease (NAFLD) and Adipose Inflammation in Human Obesity INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Validation in type 2 diabetes of a metabolomic signature of all-cause mortality DIABETES/METABOLISM RESEARCH AND REVIEWS 2023
Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus CARDIOVASCULAR DIABETOLOGY 2023
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus DIABETES & METABOLISM 2023
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus DIABETES & METABOLISM 2023
Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetes ACTA DIABETOLOGICA 2022

Progetti di Ricerca

Gruppi di ricerca

Slowly progressive autoimmune diabetes: a clinical model for novel pathways of ß-cell protection

Laboratori di ricerca

Immunità e biologia molecolare delle malattie metaboliche

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma